Crossroads Capital Views Nebius Group (NBIS) as Trading Below Earnings Power
Crossroads Capital LLC, an investment management company, released its fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Insider Monkey Blog
Crossroads Capital Investment Partners’ Q4 2025 Investor Letter
Crossroads Capital LLC, an investment management company, released its fourth-quarter 2025 investor letter.
Here’s Why Optimist Fund Trimmed Latham Group’s (SWIM) Position from 6% to 3%
Optimist Fund, an investment management company, released its fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Understanding Wayfair’s (W) Underappreciated Market Position
Optimist Fund, an investment management company, released its fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here.
ThredUp (TDUP) Stock Price Declined Despite Strong Fundamentals
Optimist Fund, an investment management company, released its fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Optimist Fund’s Views on Its Exited Position Fiverr International Ltd. (FVRR)
Optimist Fund, an investment management company, released its fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Wave Life Sciences Ltd. (NASDAQ:WVE) Q4 2025 Earnings Call Transcript
Operator: Good morning, and welcome to the Wave Life Sciences Fourth Quarter and Full Year 2025 Earnings Conference Call.
Opera Limited (NASDAQ:OPRA) Q4 2025 Earnings Call Transcript
Operator: Welcome to the Opera Limited Fourth Quarter and Full Year 2025 Earnings Call. [Operator Instructions] Please be advised that today's call is being recorded.
14 Most Undervalued NYSE Stocks to Buy According to Analysts
“I think the economic outlook is actually good,” according to Roger Altman, founder and senior chairman of Evercore, during an interview on CNBC’s Squawk Box on February...
12 Best Performing S&P 500 Stocks in the Last 10 Years
The S&P 500, the most widely used indicator of the US stock market, is difficult to beat.
Invesco Small Cap Value Fund Sold Chart Industries (GTLS) Ahead of All-Cash Baker Hughes Acquisition
Invesco Ltd's “Small Cap Value Fund” released its Q4 2025 investor letter. A copy of the letter can be downloaded here.
12 Best Gold Stocks to Buy According to Analysts
Gold stocks have been on a tear over the past year, with the precious metal smashing records on its way to record highs.
Is AbbVie Inc. (ABBV) One of the Best Cancer Stocks to Invest In Now?
AbbVie (NYSE:ABBV) is one of the best cancer stocks to invest in now.
Revolution Medicines, Inc. (RVMD) Net Loss Widens amid Progress on Clinical Trial Programs
Revolution Medicines, Inc. (NASDAQ:RVMD) is one of the best cancer stocks to invest in now. On February 26, Revolution Medicines, Inc. (NASDAQ:RVMD) CEO Mark A.
Arvinas, Inc. (ARVN) Makes Significant Progress on Oncology and Neurology Trials
Arvinas Inc. (NASDAQ:ARVN) is one of the best cancer stocks to invest in now. On February 24, Arvinas Inc.
Guardant Health, Inc. (GH) Strengthens Health Technology Portfolio with MetaSight Diagnostics Acquisition
Guardant Health Inc. (NASDAQ:GH) is one of the best cancer stocks to invest in now. On February 23, Guardant Health Inc.
Cogent Biosciences Inc. (COGT) Set for Bezuclastinib Launch, Awaiting FDA Approval
Cogent Biosciences Inc. (NASDAQ:COGT) is one of the best cancer stocks to invest in now. On February 17, CEO Andrew Robbins reiterated that Cogent Biosciences Inc.
Immunome, Inc. (IMNM) Sets Sights on $1B Opportunity amid Pipeline Development
Immunome, Inc. (NASDAQ:IMNM) is one of the best cancer stocks to invest in now. On February 14, Immunome, Inc.
Syndax Pharmaceuticals Inc. (SNDX) on a Strong Footing amid Robust Demand for Key Flagship Drugs
Syndax Pharmaceuticals (NASDAQ:SNDX) is one of the best cancer stocks to invest in now.
Schrödinger, Inc. (SDGR) Transition to Licensing Model Triggers Robust Revenue Growth
Schrodinger Inc. (NASDAQ:SDGR) is one of the best cancer stocks to invest in now. On February 25, Schrodinger Inc.
Nuvation Bio Inc. (NUVB) Amends Protocol on Safusidenib Trials in Astrocytoma
Nuvation Bio Inc. (NYSE:NUVB) is one of the best cancer stocks to invest in now. On February 9, Nuvation Bio Inc.
Summit Therapeutics Inc. (SMMT) Focused on Non-Small Cell Lung Cancer Trial of Ivonescimab
Summit Therapeutics Inc. (NASDAQ:SMMT) is one of the best cancer stocks to invest in now. On February 23, Summit Therapeutics Inc.
Janux Therapeutics, Inc. (JANX) Commences Patient Dosing of JANX011 in Autoimmune Trial
Janux Therapeutics Inc. (NASDAQ: JANX) is one of the best cancer stocks to invest in now. On February 17, Janux Therapeutics Inc.
Significant Insider Activity at East West Bancorp (EWBC) in February
In an insider activity on February 4, 2026, East West Bancorp, Inc. (NASDAQ:EWBC) saw significant sales from one of its top executives.
SEI Investments (SEIC) Partners With Pravati Capital on Finance Platform
On February 25, 2026, Pravati Capital, one of the oldest litigation finance firms in the U.S., announced a strategic partnership with SEI Investments Company (NASDAQ:SEIC) to ...
Wells Fargo Raises Globe Life (GL) Target, Keeps Overweight Rating
On February 25, 2026, Wells Fargo analyst Elyse Greenspan raised the price target on Globe Life Inc.
Bank of America Downgrades Fox (FOX), Slashes Price Target to $45
On February 25, 2026, Bank of America downgraded its rating on Fox Corporation (NASDAQ:FOX) from Buy to Underperform and cut the price target from $80 to $45.
Cognizant (CTSH) Partners With Google Cloud to Scale Agentic AI
On February 16, 2026, Cognizant Technology Solutions Corporation (NASDAQ:CTSH) announced its partnership with Google Cloud to scale agentic AI for enterprises.
KeyBanc Raises Zoom (ZM) Target to $74, Keeps Underweight Rating
On February 26, 2026, KeyBanc raised its price target on Zoom Communications, Inc. (NASDAQ:ZM) from $69 to $74 while maintaining an Underweight rating.
Significant Insider Activity at The Travelers (TRV)
On February 26, 2026, The Travelers Companies, Inc.
H.C. Wainwright Raises United Therapeutics (UTHR) Target to $600
On February 26, 2026, H.C. Wainwright raised the price target on United Therapeutics Corporation (NASDAQ:UTHR) from $525 to $600 while maintaining a Buy rating.
Bernstein Upgrades Newmont (NEM) to Outperform, Sets $157 Target Price
On February 27, 2026, Newmont Corporation (NYSE:NEM) saw its rating from Bernstein upgraded from Market Perform to Outperform.
Barclays Reiterates Buy Rating on Charles Schwab (SCHW) Shares Stock
On February 17, 2026, Barclays analyst Benjamin Budish reiterated a Buy rating on The Charles Schwab Corporation (NYSE:SCHW) and kept a price target of $120.
Truist Raises Target on BILL Holdings (BILL), Keeps Buy Rating
Truist raised its price target on BILL Holdings, Inc. (NYSE:BILL) from $58 to $59 and keeps a Buy rating on the stock, on February 10, 2026.
Analysts Maintain Hold Rating on PepsiCo (PEP)
On February 20, 2026, Wells Fargo analyst Christopher Carey maintained a Hold rating on PepsiCo, Inc. (NASDAQ:PEP) with a price target of $165.
Barclays Upgrades Etsy (ETSY) to Overweight as Truist Raises Target
On February 20, 2026, Barclays upgraded its rating on Etsy, Inc. (NYSE:ETSY) from Equal Weight to Overweight with a price target of $72.
Uniti Group (UNIT) Accelerates 2026 Expansion With FastWaves Launch Program
Uniti Wholesale, a dedicated business unit of Uniti Group Inc.
Wells Fargo Maintains Hold on Hewlett Packard Enterprise (HPE)
On February 19, 2026, Wells Fargo analyst Aaron Rakers reiterated a Hold rating on Hewlett Packard Enterprise Company (NYSE:HPE) with a price target of $26.00.
Goldman Sachs Cuts Pinterest (PINS) Target as RBC Downgrades Shares
On February 13, 2026, Pinterest, Inc. (NYSE:PINS) saw its price target from Goldman Sachs lowered from $32 to $23.
UBS Upgrades Southwest Airlines (LUV) to Buy, Raises Target by $22
On February 17, 2026, UBS upgraded Southwest Airlines Co. (NYSE:LUV)’s ratings from Neutral to Buy and raised the price target on the stock from $51 to $73.
Veritas Downgrades Suncor Energy (SU) to Sell
On February 6, 2026, independent equity research firm Veritas downgraded Suncor Energy Inc. (NYSE:SU) from Reduce to Sell, with a price target of C$64.
Barclays Raises Phillips 66 (PSX) Target to $158, Keeps Equal Weight Rating
On February 20, 2026, Barclays raised the price target on Phillips 66 (NYSE:PSX) from $142 to $158 while maintaining an Equal Weight rating.
Stifel Raises Triple Flag Precious Metals (TFPM) Target, Maintains Buy
On February 10, 2026, Triple Flag Precious Metals Corp. (NYSE:TFPM) saw its price target from Stifel raised from C$58 to C$65.
Acadia Realty Trust, TPG (TPG) Complete $440M Portfolio Transaction
On February 25, Acadia Realty Trust completed a $440 million portfolio transaction with TPG Inc.
BeOne Medicines (ONC) Reports $1.5B Revenue for Q4, $1.1B from Lymphoma Treatment
On February 26, BeOne Medicines AG (NASDAQ:ONC) reported total global revenues of $1.5 billion for the fourth quarter of 2025 and $5.3 billion for 2026, increases of 33% and 40...
Analyst Cautious of Zillow (Z) Ahead of Google NotebookLM Partnership
On February 19, Zillow Group Inc.
BMO Capital, Needham Cut CoStar Group (CSGP) Price Target
On February 26, BMO Capital analyst Jeffrey Silber cut the price target on CoStar Group Inc. (NASDAQ:CSGP) to $53 from $72 while keeping a Market Perform rating on the shares.
Stifel Lowers Credo (CRDO) Price Target Despite Tensorwave AI Infrastructure Collaboration
On February 27, Stifel lowered its price target on Credo Technology Group Holding Ltd (NASDAQ:CRDO) to $200 from $225 while maintaining a Buy rating.
Kratos (KTOS) Prices Common Stock Offering at $84 Per Share, Expects $1.17B in Proceeds
On February 26, Kratos Defense & Security Solutions Inc. (NASDAQ:KTOS) priced an underwritten public offering of 14,285,714 shares of common stock at $84.00 per share.
Coupang (CPNG) Records $8.8B Q4 Revenue, $26M Loss Amid Data Breach Backlash
On February 26, Coupang Inc.
Hedge Fund Resource Center
